Canary Health Technologies
Canary Global Inc. pioneers gene therapy and AI-driven precision diagnostics to develop next-generation treatments for diseases affecting 300 million people globally.
About Canary Global Inc.
Canary Global Inc. is a pioneer in gene therapy, focusing on durable solutions for diseases with limited treatment options. The company leverages its proprietary platform that utilizes miRNA biomarkers to address the root causes of diseases. Canary Global Inc. is developing next-generation treatments for diseases affecting 300 million people globally and is committed to revolutionizing healthcare through its innovative approaches.
Proprietary Technologies
Utilizing a proprietary platform, Canary Global Inc. combines vectorized antibodies with the replacement of mutant genes to treat neurodegenerative and rare diseases effectively. These antibodies are designed to bind and neutralize misfolded proteins, preventing their aggregation and toxicity. The company's LNP-mRNA technology allows for the rapid development of therapies by delivering functional mRNA to specific cells, enhancing treatment efficacy. Their novel formulations ensure stability and efficient intracellular release of mRNA, crucial for therapeutic success.
Innovative Diagnostics and COVID-19 Testing
Canary Global Inc. has made significant strides in diagnostics, developing molecular point-of-care (POC) platforms with high sensitivity and specificity. The company has produced a 20-minute handheld COVID-19 saliva test with CE Mark certification, providing PCR quality results. Additionally, Canary Global has created the world's first point-of-care real-time COVID-19 variant test and a 2-minute digital saliva test with 98% sensitivity, both achieving CE Mark. The company continues R&D to further advance these technologies.
Collaborations and Partnerships
To advance its innovative technologies, Canary Global Inc. has partnered with White Plains Hospital. This collaboration aims to drive the clinical development of the company's cutting-edge diagnostic and therapeutic solutions. Such partnerships are integral to Canary Global’s mission of transforming healthcare and improving patient outcomes through their next-generation technologies.
Mission and Vision
Canary Global Inc.'s mission is to harness the power of gene therapy and AI-driven precision diagnostics to transform health care, empowering individuals to live healthier and longer lives. By developing novel biomarkers, the company aims to predict disease risk, detect disease presence, and monitor therapy responses. Canary Global's commitment to innovation and advancement in scientific knowledge positions it at the forefront of the biotechnology sector.